Limelight Enables Online Education With Multiple Customer Wins Across the World
17.9.2020 19:20:00 EEST | Business Wire | Press release
With online learning filling an unprecedented need to maintain educational opportunities worldwide, Limelight Networks, Inc. (Nasdaq: LLNW), a leading provider of content delivery network (CDN) and edge cloud services, is helping EdTech companies worldwide provide content to parents, students and teachers.
The EdTech industry has been transformed almost overnight. In just a few months, remote learning has gone from a burgeoning business to a virtual lifeline for students and families everywhere. According to Limelight’s most recent global market research, 83 percent of those surveyed believe that video-based learning is here to stay. Companies all over the world have chosen Limelight to deliver these vital services, two of which are featured below:
Learning Ally , a leading nonprofit education organization, works with children who have reading challenges. Its Audiobook Solution offers an award-winning reading accommodation used in 18,500 schools. With the infrastructure and support of Limelight’s global private network, Ally was able to quickly absorb a wave of new subscribers and expand e-learning services. “In a matter of weeks, we added 13,800 educators and more than 130,000 new students to the Learning Ally Audiobook Solution. The Limelight CDN was able to support us in meeting the requirements for the surge of audiobook listeners,” said Cynthia Hamburger, CIO and COO at Learning Ally.
When schools closed during the pandemic in Canada, Groupe Média TFO (TFO), a French-language specialty channel, was tapped to create educational content for the online portal opened by its Minister of Education to serve more than 5 million school children. By leveraging the Limelight Video Platform to manage and distribute its online video at scale, TFO was able to quickly create and stream more content and handle a 60 percent increase in traffic during the stay-at-home order. “As a result of COVID-19, we had a very short turnaround to support the Ministry of Education’s learn-at-home initiative and play an important role in the move to online learning with our rich collection of educational videos. As we reached an unprecedented number of visits on our sites, we were hit with massive growth in bandwidth. Thankfully, our CDN infrastructure was built on Limelight, so we were not only ready, but we were also able to expand the initiative nationwide to support as many families and students as possible,” said Micaël N’Goran, Director, Solutions and Optimization at Groupe Média TFO.
“At Limelight, we’re passionate about delivering the highest quality online video and edge cloud services for customers across industries,” said Dan Carney, SVP of Network Operations at Limelight. “Serving all of our clients is satisfying, but supporting the educational needs of children, parents and educators globally during this difficult time is particularly motivating.”
To find out more on how Limelight is enabling EdTech clients, see here for detailed case studies.
About Limelight
Limelight Networks, Inc. (NASDAQ: LLNW), a leading provider of digital content delivery, video, cloud security, and edge computing services, empowers customers to provide exceptional digital experiences. Limelight’s edge services platform includes a unique combination of global private infrastructure, intelligent software, and expert support services that enable current and future workflows. For more information, visit www.limelight.com, follow us on Twitter, Facebook, and LinkedIn.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200917005807/en/
Contact information
Stephanie Epstein
SHIFT Communications
Limelight@shiftcomm.com
617-779-1800
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 19:19:00 EEST | Press release
Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease and lung cancer,” she added. “More broadly, it reinforces the agency’s science-based approach to evaluating products across the co
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 18:00:00 EEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 17:13:00 EEST | Press release
For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and more practical: what it takes to make a specific, high-stakes determination reliable, fast and affordable at scale. A vertical, domain-focused process, gro
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 17:08:00 EEST | Press release
Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d
Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 17:00:00 EEST | Press release
Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by market capitalization and is home to world-leading companies such as Samsung Electr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom